John Rotrosen, MD

Dr. Rotrosen is Professor of Psychiatry at New York University School of Medicine. He attended NYU School of Medicine from 1968 to 1972 and completed a Psychiatry Research Residency at NYU and Bellevue Hospital in 1976. Subsequent research training was supported in part by an NIMH Research Scientist Career Development Award under the mentorship of Drs. Samuel Gershon and Burt Angrist. From 1980 through 1997, he served as Chief, Psychiatry Service, and from 1997 to 2013, as Associate Chief of Staff for Mental Health Research at the VA Medical Center in New York. His research has focused on addictive disorders, attention deficit hyperactivity disorder and schizophrenia and movement disorders, addressing pathophysiology, pharmacological and behavioral intervention, and translation to community settings. His research group has contributed to the development of many of the atypical antipsychotic agents and to the development of new medications, novel forms of medication delivery, and behavioral therapies for opiate, cocaine, alcohol and nicotine dependence. He was PI of the NY VAMC-based NIDA/VA Medications Development Research Unit from 1995-2001 and PI of the NY Node of the NIDA Clinical Trials Network (and currently one of the two PIs of the merged Greater NY Node). He recently served on the National Advisory Council on Drug Abuse (NIDA Council) and previously on NIMH Council. Current work in addictive disorders includes studies on clinical genetics, neuroimaging, medication and behavioral therapies development, implementation in mainstream healthcare settings, services and healthcare disparities, and practice improvement. He chairs and serves as a member of data monitoring and safety boards and as a medical monitor for several studies and serves as a key mentor to a multi-disciplinary group of trainees, K-awardees and junior faculty.